Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas
SCIEX Launches the Intabio ZT System at ASMS 2023
At ASMS 2023, SCIEX launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform combining imaged capillary isoelectric focusing separation and UV detection.
Oncodesign Services and Veritas In Silico Enter Into Business Cooperation
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion As mRNA Manufacturing Facility Nears Completion
TriLink’s construction of the new 32,000-square-foot, cGMP-grade facility solidifies its commitment to advancing the field as more mRNA-based therapeutics and vaccines enter later-stage clinical trials.
Cellular Origins Launches its Configurable Robotic Platform, Constellation
Cellular Origins has announced the launch of Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.
GenNext® Technologies Announces Partnership with Emery Pharma
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announced today that it is collaborating with Emery Pharma.
Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
Form Bio Selected by Google Cloud To Help Organizations Adopt New AI-Powered Life Sciences Solutions
Form Bio announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life science companies and academic institutions.
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
Waters™ Corporation has completed its acquisition of Wyatt Technology, a developer of innovative light scattering and field-flow fractionation instruments, software, accessories and services.
Efficient Transduction of CAR Into T Cells
AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
Form Bio Announces AI Solution Set for Predicting and Optimizing Cell and Gene Therapy Manufacturability
Form Bio has announced the launch of FORMsightAI, a new, AI-based solution set for predicting and optimizing manufacturing outputs of cell and gene therapy constructs.